International Patent: USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF DISEASE

GENEVA, Sept. 24 -- CRINETICS PHARMACEUTICALS, INC. filed a patent application (US2026/019292) for “USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF DISEASE”. With publication no. WO/2026/198396, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/4709

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....